Difficulty: Medium
Average Score: 87%
Practice
A 29-year-old man with spinal cord injury and with chronic gastric immotility syndrome has failed therapy with numerous cholinoimimetic agents. He has begun on therapy with physostigmine. Unfortunately, a supratherapeutic dose is administered to the patient. Which of the following effects must the treating physician be aware of?
Correct answer
A
Rationale
Physostigmine, a cholinesterase inhibitor, can cause excessive cholinergic stimulation, leading to convulsions and other central nervous system effects if overdosed.